LA Times: Supreme Court spurns challenge to stem cell research
By David G. Savage
The Los Angeles Times
January 7, 2013
WASHINGTON -- The Supreme Court has turned away a challenge to President Obama’s policy of expanding government-funded research using embryonic stem cells that scientists say may offer hope for new treatments for spinal injuries and Parkinson’s disease.
The court’s action brings a quiet end to a lawsuit that briefly threatened to derail all funding for such research.
A federal judge in Washington in 2010 ordered the National Institutes of Health to halt funding of the research, citing a long-standing congressional ban on spending for research in which “human embryos are destroyed.”
But an appeals court overturned that order and ruled last year that the ban applied only to research which destroyed human embryos so as to obtain stem cells.
President George W. Bush in 2001 had allowed limited research on several stem cell lines that were already in existence. Upon taking office in 2009, President Obama went further and said NIH could conduct “scientifically worthy human stem cell research to the extent permitted by law.” Under guidelines issued by NIH, researchers can used stem line cells derived from donated frozen embryos that are no longer needed for fertility treatments.
The three-judge panel that upheld the Obama administration’s guidelines was made up Chief Judge David Sentelle, a Reagan appointee; Judge Karen Henderson, appointed by President George H.W. Bush; and Judge Janice Rogers Brown, an appointee of President George W. Bush.
Two researchers who work with adult stem lines, including Dr. James Sherley of the Boston Biomedical Research Institute, brought the lawsuit. They were represented by several groups, including the Law of Life Project. Samuel Casey, the group’s general counsel, called the human stem cell research “an ethical tragedy as well as a waste of the taxpayer’s money.”
They appealed to the high court in the fall, but the justices denied the appeal without comment or dissent in the case, Sherley v. Sebelius.
Taubman-sponsored research offers breast tumor insights
Taubman Emerging Scholar Dr. Scott Tomlins has authored a new study about phyllodes tumors.
New U-M President visits Taubman Institute
The Institute hosted a fellow clinician-scientist when the University of Michigan’s new president paid a visit to the A. Alfred Taubman Biomedical Science Research Building.
Familial ALS affects generations
Detroit News column featuring Dr. Eva Feldman depicts the toll of the disease on one Metro Detroit family
news & events
In the News
Taubman Emerging Scholar makes strides against cancer
Erika Newman, M.D., has identified a characteristic of deadly childhood neuroblastoma that may pave the way for more effective treatments.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.